Published on 1 Feb 2023 on Zacks via Yahoo Finance
Lannett (LCI) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.41. This compares to loss of $0.39 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 17.07%. A quarter ago, it was expected that this generic drug company would post a loss of $0.46 per share when it actually produced a loss of $0.42, delivering a surprise of 8.70%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.